GW Pharmaceuticals PLC ADR

Historical 13F Holders

Symbol
GWPH
CUSIP
36197T103
All holders as of
Q2 2024
Type
Equity
Class
ADS
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q2 1 38.0 $8.24 k
2022 Q1 1 109 $24.0 k
2021 Q2 2 30.0 $3.00 k
2021 Q1 322 24.4 M $5.28 B
2020 Q4 316 24.8 M $2.89 B
2020 Q3 314 25.2 M $2.44 B
2020 Q2 333 25.3 M $3.13 B
2020 Q1 325 26.4 M $2.33 B
2019 Q4 360 25.1 M $2.60 B
2019 Q3 358 25.4 M $2.87 B
2019 Q2 370 26.6 M $4.52 B
2019 Q1 361 24.2 M $4.00 B
2018 Q4 311 24.0 M $2.29 B
2018 Q3 306 21.2 M $3.58 B
2018 Q2 283 21.4 M $2.98 B
2018 Q1 216 21.9 M $2.46 B
2017 Q4 232 23.0 M $3.03 B
2017 Q3 208 20.7 M $2.10 B
2017 Q2 199 19.0 M $1.91 B
2017 Q1 215 19.2 M $2.32 B
2016 Q4 200 20.0 M $2.23 B
2016 Q3 178 18.2 M $2.41 B
2016 Q2 152 15.1 M $1.38 B
2016 Q1 133 14.2 M $1.03 B
2015 Q4 132 13.5 M $937 M
2015 Q3 130 15.3 M $1.30 B
2015 Q2 120 13.3 M $1.63 B
2015 Q1 104 10.7 M $975 M
2014 Q4 93 8.10 M $548 M
2014 Q3 98 8.04 M $650 M
2014 Q2 100 8.29 M $889 M
2014 Q1 75 7.52 M $446 M